Literature DB >> 28994829

Bladder cancer: Benefit of adjuvant chemotherapy in UTUC unclear.

Clemens Thoma.   

Abstract

Entities:  

Year:  2017        PMID： 28994829     DOI： 10.1038/nrurol.2017.170

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration.

Authors:  Andrea Necchi; Salvatore Lo Vullo; Luigi Mariani; Marco Moschini; Kees Hendricksen; Michael Rink; Roman Sosnowski; Jakub Dobruch; Jay D Raman; Christopher G Wood; Vitaly Margulis; Morgan Roupret; Alberto Briganti; Francesco Montorsi; Evanguelos Xylinas; Shahrokh F Shariat
Journal:  BJU Int       Date:  2017-10-12       Impact factor: 5.588
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.